Javascript must be enabled to continue!
Peritoneal Dialysis in Croatia
View through CrossRef
Objective
To present the state of renal replacement therapy (RRT) in Croatia, assess the quality of dialytic treatment, verify the value of peritoneal dialysis (PD), and promote expansion of PD in Croatia based on results attained locally. According to the integrative care concept, PD is the best way to start life-long RRT. Croatian nephrologists have adopted the policy of increasing the use of PD. However, evidence for recommendations were obtained in specific circumstances and might not be relevant elsewhere. The aim of this observational study is to compare the outcome of PD with that of hemodialysis (HD), as practiced in Croatia.
Methods
Since 2000, the Croatian Registry for Renal Replacement Therapy has been collecting individual patient data for all patients on RRT, with complete coverage.
Results
As of 31 December 2004, there were 251 prevalent patients on PD (continuous ambulatory PD and automated PD) in Croatia, accounting for 7% of all patients on RRT and giving a prevalence of 57 patients per million population. From 1 January 2000 to 31 December 2004, 377 patients started PD and were followed from the first day of RRT. For 80% of them, PD was the first mode of RRT. The probability of staying on PD for 5 years was 31% [95% confidence interval (CI) 29 - 32]. Five-year technique survival (excluding transplanted, recovered, and deceased patients) was 68% (95%CI 65 - 70). For survival analysis and comparison between PD and HD, only patients on the same method from the start of their RRT were included. Patients changing treatment were censored after 60 days (intention-to-treat analysis). Unadjusted 5-year survival in the PD-first group (301 patients) was 60% (95%CI 54 - 65), which is significantly better than in the 2789 HD-first patients (42%, 95%CI 40 – 44; log-rank p < 0.0001). When data were stratified for age and diabetes, 5-year mortality rates on HD were higher in all strata. Only in patients ≥ 70 years old was the advantage of PD less impressive. Standardized mortality ratio was 1.85 ( p < 0.01) in favor of PD. Hazard ratio of HD versus PD was 2.1 (95%CI 1.6 – 2.8). After adjustments for age, gender, diabetes, and nephroangiosclerosis, the hazard ratio settled at 1.5 (95%CI 1.1 – 1.9).
Conclusion
In Croatia, PD is used mostly as the first RRT. Almost one third of patients continue PD for 5 years due to good patient and technique survival. Starting RRT with PD offers 50% superior 5-year survival in comparison to HD. Dialysis patients in Croatia would benefit from an expanded PD program.
Title: Peritoneal Dialysis in Croatia
Description:
Objective
To present the state of renal replacement therapy (RRT) in Croatia, assess the quality of dialytic treatment, verify the value of peritoneal dialysis (PD), and promote expansion of PD in Croatia based on results attained locally.
According to the integrative care concept, PD is the best way to start life-long RRT.
Croatian nephrologists have adopted the policy of increasing the use of PD.
However, evidence for recommendations were obtained in specific circumstances and might not be relevant elsewhere.
The aim of this observational study is to compare the outcome of PD with that of hemodialysis (HD), as practiced in Croatia.
Methods
Since 2000, the Croatian Registry for Renal Replacement Therapy has been collecting individual patient data for all patients on RRT, with complete coverage.
Results
As of 31 December 2004, there were 251 prevalent patients on PD (continuous ambulatory PD and automated PD) in Croatia, accounting for 7% of all patients on RRT and giving a prevalence of 57 patients per million population.
From 1 January 2000 to 31 December 2004, 377 patients started PD and were followed from the first day of RRT.
For 80% of them, PD was the first mode of RRT.
The probability of staying on PD for 5 years was 31% [95% confidence interval (CI) 29 - 32].
Five-year technique survival (excluding transplanted, recovered, and deceased patients) was 68% (95%CI 65 - 70).
For survival analysis and comparison between PD and HD, only patients on the same method from the start of their RRT were included.
Patients changing treatment were censored after 60 days (intention-to-treat analysis).
Unadjusted 5-year survival in the PD-first group (301 patients) was 60% (95%CI 54 - 65), which is significantly better than in the 2789 HD-first patients (42%, 95%CI 40 – 44; log-rank p < 0.
0001).
When data were stratified for age and diabetes, 5-year mortality rates on HD were higher in all strata.
Only in patients ≥ 70 years old was the advantage of PD less impressive.
Standardized mortality ratio was 1.
85 ( p < 0.
01) in favor of PD.
Hazard ratio of HD versus PD was 2.
1 (95%CI 1.
6 – 2.
8).
After adjustments for age, gender, diabetes, and nephroangiosclerosis, the hazard ratio settled at 1.
5 (95%CI 1.
1 – 1.
9).
Conclusion
In Croatia, PD is used mostly as the first RRT.
Almost one third of patients continue PD for 5 years due to good patient and technique survival.
Starting RRT with PD offers 50% superior 5-year survival in comparison to HD.
Dialysis patients in Croatia would benefit from an expanded PD program.
Related Results
Assessment of implementation of the Pradhan Mantri national dialysis Programme in Hospitals in Delhi
Assessment of implementation of the Pradhan Mantri national dialysis Programme in Hospitals in Delhi
Background: Annual-demand for haemodialysis-sessions in India is 3.4 Crores. To make Renal-care-services affordable to APL and free to BPL, Ministry of Health and Family Welfare la...
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...
Abstract B140: Autologous human growing tumor model and its immunological relevance for cancer immunology research
Abstract B140: Autologous human growing tumor model and its immunological relevance for cancer immunology research
Abstract
Background: Tumors grow in accordance with immunoediting. If we can see the changes of immune characteristics in the microenvironment during tumor growth, w...
Factors Associated With Dialysis Withdrawal In Dialysis Patients
Factors Associated With Dialysis Withdrawal In Dialysis Patients
Abstract
Background: Research on the factors associated with dialysis withdrawal in dialysis patients has been limited. Authors have used different definitions for dialysis...
FC 117TIME TRENDS IN PROBABILITY OF STARTING HOME DIALYSIS OVER A 20 YEAR PERIOD: A DUTCH REGISTRY STUDY
FC 117TIME TRENDS IN PROBABILITY OF STARTING HOME DIALYSIS OVER A 20 YEAR PERIOD: A DUTCH REGISTRY STUDY
Abstract
Background and Aims
A growing number of patients suffers from End Stage Kidney Disease(ESKD), causing a logistical and ...
Dialysis for Chronic Kidney Failure
Dialysis for Chronic Kidney Failure
ImportanceMore than 3.5 million people worldwide and 540 000 individuals in the US receive maintenance hemodialysis or peritoneal dialysis for the treatment of chronic kidney failu...
Effects of Intraperitoneal Hyaluronan on Peritoneal Fluid and Solute Transport in Peritoneal Dialysis Patients
Effects of Intraperitoneal Hyaluronan on Peritoneal Fluid and Solute Transport in Peritoneal Dialysis Patients
← Background
Hyaluronan (HA) is a glycosaminoglycan found in connective tissues and tissue spaces, including the peritoneal cavity. In vivo studies in a rat mod...
Hyaluronan reduces colitis-induced intraperitoneal inflammation during peritoneal dialysis
Hyaluronan reduces colitis-induced intraperitoneal inflammation during peritoneal dialysis
Background: Peritoneal dialysis induces the inflammatory response within the peritoneal cavity, which contributes to the progressive damage of the peritoneum. Due to close contact ...

